Christoph Driessen Selected Research

Christoph Driessen Research Topics

Disease

40	Multiple Myeloma 01/2023 - 04/2007
22	Neoplasms (Cancer) 10/2023 - 02/2008
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2019
6	Multiple Sclerosis 01/2009 - 11/2002
5	Infections 01/2023 - 04/2007
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2023 - 07/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 03/2016
2	Melanoma (Melanoma, Malignant) 10/2023 - 01/2019
2	COVID-19 01/2023 - 01/2023
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 08/2003
2	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2007
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016 - 08/2015
2	Hodgkin Disease (Hodgkin's Disease) 01/2008 - 01/2003
1	Pneumonia (Pneumonitis) 04/2024
1	Dysgeusia (Parageusia) 10/2023
1	Cytopenia 01/2023
1	Cytokine Release Syndrome 01/2023
1	cell-associated neurotoxicity 01/2023
1	Lactic Acidosis 10/2022
1	Plasma Cell Leukemia 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2021
1	Polycythemia Vera 10/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Residual Neoplasm 06/2020
1	Plasmacytoma 06/2020
1	Rheumatoid Arthritis 01/2020
1	Ankylosing Spondylitis 01/2020
1	Psoriatic Arthritis 01/2020

Drug/Important Bio-Agent (IBA)

22	Proteasome InhibitorsIBA 10/2023 - 02/2008
15	Bortezomib (Velcade)FDA Link 10/2023 - 07/2008
12	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 02/2008
7	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2016
6	Nelfinavir (Viracept)FDA Link 01/2023 - 03/2014
6	carfilzomibIBA 01/2023 - 08/2015
5	Immune Checkpoint InhibitorsIBA 04/2024 - 04/2019
5	HIV Protease InhibitorsIBA 01/2021 - 07/2008
5	AutoantigensIBA 01/2009 - 11/2002
5	Myelin Basic ProteinIBA 01/2009 - 11/2002
4	Peptide Hydrolases (Proteases)FDA Link 10/2008 - 05/2003
3	ibrutinibIBA 10/2023 - 05/2015
3	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023 - 05/2015
3	Messenger RNA (mRNA)IBA 01/2023 - 05/2003
3	VaccinesIBA 01/2023 - 12/2021
3	Lenalidomide (CC 5013)FDA Link 11/2021 - 03/2017
3	ixazomibIBA 10/2021 - 10/2018
3	AntigensIBA 01/2021 - 04/2007
3	Dexamethasone (Maxidex)FDA LinkGeneric 06/2020 - 03/2017
3	invariant chain (Ii-Key)IBA 01/2020 - 05/2003
3	Monoclonal AntibodiesIBA 04/2019 - 01/2003
3	Rituximab (Mabthera)FDA Link 08/2015 - 01/2003
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 12/2017
2	AutoantibodiesIBA 04/2024 - 01/2020
2	AntibodiesIBA 04/2024 - 01/2023
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2023
2	Peptides (Polypeptides)IBA 07/2021 - 01/2020
2	EnzymesIBA 01/2020 - 12/2007
2	Phosphotransferases (Kinase)IBA 11/2019 - 04/2019
2	NivolumabIBA 07/2019 - 04/2019
2	Lopinavir FDA Link 01/2018 - 03/2014
2	Ritonavir (Norvir)FDA Link 03/2014 - 07/2008
2	CathepsinsIBA 05/2007 - 08/2003
1	Immunoglobulin G (IgG)IBA 04/2024
1	IgA receptor (protein B)IBA 04/2024
1	Interferon-gamma (Interferon, gamma)IBA 04/2024
1	Surface-Active Agents (Surfactants)IBA 04/2024
1	remdesivirIBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	pomalidomideIBA 01/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	molnupiravirIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	ProteomeIBA 01/2022
1	InterferonsIBA 10/2021
1	Interferon-alpha (Interferon Alfa)IBA 10/2021
1	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2021
1	melflufenIBA 07/2021
1	Membrane LipidsIBA 01/2021
1	EpitopesIBA 01/2021
1	LipidsIBA 01/2021
1	Prednisone (Sone)FDA LinkGeneric 06/2020
1	Melphalan (Alkeran)FDA LinkGeneric 06/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020

Therapy/Procedure

19	Therapeutics 04/2024 - 10/2006
3	Drug Therapy (Chemotherapy) 10/2023 - 06/2020
3	Immunotherapy 07/2019 - 04/2007
1	Acupressure (Shiatsu) 10/2023
1	Complementary Therapies (Alternative Medicine) 10/2023
1	Acupuncture Therapy 10/2023
1	Premedication 01/2023
1	Stem Cell Transplantation 06/2020
1	Surgical Instruments (Clip) 01/2020